Last update 29 Aug 2025

DigmBio. Inc.

Holding Company|2020|South Korea|
www.digmbio.com

Overview

Tags

Nervous System Diseases
Neoplasms
Skin and Musculoskeletal Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Neoplasms1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
TASR(serine and arginine rich splicing factor 10)2
PARP1(Poly (ADP-Ribose) polymerase 1)1

Related

3
Drugs associated with DigmBio. Inc.
DM-5167
Target
PARP1
Mechanism
PARP1 inhibitors
Active Org.
DigmBio. Inc. [+1]
Originator Org.
DigmBio. Inc. [+1]
Active Indication
Advanced breast cancer [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
DM-3159
Target
TASR
Mechanism
TASR modulators
Active Org.
DigmBio. Inc.
Originator Org.
DigmBio. Inc.
Active Indication
Alzheimer Disease
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
DM-3190
Target
TASR
Mechanism
TASR modulators
Active Org.
DigmBio. Inc.
Originator Org.
DigmBio. Inc.
Active Indication
Parkinson Disease
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with DigmBio. Inc.
NCT07101601
/ RecruitingPhase 1
An Open-label, Dose-finding, Phase 1 Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile, and to Explore the Pharmacodynamic Profile of DM5167 in Patients With Advanced Solid Tumors
100 Clinical Results associated with DigmBio. Inc.
Login to view more data
0 Patents (Medical) associated with DigmBio. Inc.
Login to view more data
100 Deals associated with DigmBio. Inc.
Login to view more data
100 Translational Medicine associated with DigmBio. Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
DM-5167
 ( PARP1 )		Advanced Malignant Solid Neoplasm
More
Phase 1
DM-3190
 ( TASR )		Parkinson Disease
More
Preclinical
DM-3159
 ( TASR )		Alzheimer Disease
More
Preclinical
DM1050
Nonalcoholic Steatohepatitis
More
Discontinued
DM-3100
 ( TAS1R3 )		Alzheimer Disease
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free